166 related articles for article (PubMed ID: 844038)
1. A time factor in the success or failure of immune rejection of transplanted tumors.
Vaage J
Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
[TBL] [Abstract][Full Text] [Related]
2. Serum therapy for radiation-induced impairment of immune resistance to metastasis.
Vaage J; Agarwal S
Cancer Res; 1977 Oct; 37(10):3556-60. PubMed ID: 908007
[TBL] [Abstract][Full Text] [Related]
3. Protective serum effects in tumor immunity.
Vaage J
Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
[TBL] [Abstract][Full Text] [Related]
4. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
Vaage J; Agarwal S
Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell infiltrate of the primary tumor as a source of early systemic protection against metastases in mice.
Vaage J; Pepin KG
J Natl Cancer Inst; 1983 Jul; 71(1):147-55. PubMed ID: 6345879
[TBL] [Abstract][Full Text] [Related]
6. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
Townsend SE; Su FW; Atherton JM; Allison JP
Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298
[TBL] [Abstract][Full Text] [Related]
7. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
BasombrÃo MA; Prehn RT
Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
[No Abstract] [Full Text] [Related]
8. Macrophage processing of antigen for induction of tumor immunity.
Brunda MJ; Raffel S
Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
[TBL] [Abstract][Full Text] [Related]
9. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
Likhite VV
J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
[TBL] [Abstract][Full Text] [Related]
10. The specificity of concomitant tumor immunity at large tumor volumes.
Deckers PJ; Pardridge DH; Wang BS; Mannick JA
Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
[TBL] [Abstract][Full Text] [Related]
11. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
[TBL] [Abstract][Full Text] [Related]
12. [Role of the cellular inoculation dose in the development of the inhibitory effect of transplantable tumors on metastasis].
Arkhipov SA; Iunker VM; Gruntenko EV
Vopr Onkol; 1985; 31(3):77-83. PubMed ID: 3992963
[TBL] [Abstract][Full Text] [Related]
13. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
[TBL] [Abstract][Full Text] [Related]
14. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
15. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
Vaage J; Medina D
Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
[TBL] [Abstract][Full Text] [Related]
16. Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity.
Donawho CK; Pride MW; Kripke ML
Cancer Res; 2001 Jan; 61(1):215-21. PubMed ID: 11196164
[TBL] [Abstract][Full Text] [Related]
17. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
Greene MI; Fujimoto S; Sehon AH
J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
[TBL] [Abstract][Full Text] [Related]
19. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor.
Vaage J; Pepin KG
Cancer Res; 1985 Feb; 45(2):659-66. PubMed ID: 3967241
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
Lopez DM; Sigel MM; Charyulu VL
J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
